1 capsule contains:
Active ingredient: Standardized lyophilisate of bacterial lysates (OM-85) - 20.0 mg
(active substance "OM-85" contains lyophilized bacterial lysates - 3.50 mg (Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus viridans, Streptococcus pyogenes, Klebsiella pneumoniae, Klebsiella ozaenae, Staphylococcus aureus, Moraxella catarrhalis)
Excipients: propyl gallate (anhydrous), sodium glutamate (anhydrous), magnesium stearate, pregelatinized starch, mannitol.
Capsule shell: E132 indigotine, E171 titanium dioxide, gelatin.
Broncho-munal® P has an immunostimulating effect, strengthening the immune system against respiratory tract infections.
In patients receiving Broncho-munal® P, the protective properties of the body against bacteria and viruses are enhanced.
After taking the capsule, the bacterial lysate accumulates in the Peyer's patches of the mucous membrane of the gastrointestinal tract, in particular, located in the small intestine. Antigen-presenting cells in Peyer's patches are activated by bacterial lysate and subsequently stimulate other cell types (B-lymphocytes) responsible for specific immunity. This leads to an increase in the number of circulating B-lymphocytes, which leads to an increase in the production of polyclonal antibodies, especially serum IgG and IgA, secreted by the respiratory mucosa and salivary glands.
Also, the drug has an effect on nonspecific immunity, stimulating leukocytes, which is characterized by an increase in the number of cells of the myeloid and lymphoid series,
as well as a selective increase in the expression of receptors on their surface. In patients receiving Broncho-munal® P, the protective properties of the body against bacteria and viruses are enhanced.
Clinically, Broncho-munal® P reduces the frequency of acute respiratory tract infections, reduces the duration of their course, reduces the likelihood of exacerbations of chronic bronchitis, and also increases the body's resistance to infections of the respiratory system. This reduces the need for the use of other drugs, especially antibiotics.
The drug is taken 1 capsule per day in the morning, on an empty stomach, 30 minutes before meals.
For children under 3 years of age, or if it is difficult for a child to swallow the capsule, it should be opened, the contents mixed with a small amount of liquid (tea, milk or juice).
• To prevent recurrent infections of the respiratory tract and exacerbations of chronic bronchitis, the drug is used in three courses of 10 days, the interval between courses is 20 days.
• As part of the complex therapy of acute respiratory tract infections, the drug is used until the symptoms disappear, but not less than 10 days. During antibiotic therapy, Broncho-munal® P should be taken in combination with antibiotics from the start of treatment.
For the next 2 months, prophylactic use of the drug is possible: courses for 10 days, the interval between courses is 20 days.
